An embryo-specific expressing TGF- family protein, growth-differentiation factor 3 (GDF3), augments progression of B16 melanoma

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Ehira, Nobuyuki ^a   Oshiumi, Hiroyuki ^a   Matsumoto, Misako ^a   Kondo, Takeshi ^a   Asaka, Masahiro ^a   Seya, Tsukasa ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD24 ANTIGEN; GROWTH DIFFERENTIATION FACTOR 3; HERMES ANTIGEN; CD24A PROTEIN, MOUSE; CD44 PROTEIN, MOUSE; GDF3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER STEM CELL; CANCER TRANSPLANTATION; CONTROLLED STUDY; EMBRYONAL CARCINOMA; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE INDUCTION; GENE OVEREXPRESSION; GERM CELL TUMOR; LIVER CELL CARCINOMA; MELANOMA B16; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEMINOMA; TUMOR GROWTH; TUMOR PROMOTION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL PROLIFERATION; DISEASE COURSE; EXPERIMENTAL MELANOMA; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; LIVER TUMOR; METABOLISM; METASTASIS; TIME; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; ANTIGENS, CD24; ANTIGENS, CD44; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH DIFFERENTIATION FACTOR 3; IMMUNITY, INNATE; LIVER NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; TIME FACTORS; TRANSFECTION; TUMOR BURDEN;

EID: 77957893716     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-135     Document Type: Article

References (38)

1. Isolation of Vgr-2, a novel member of the transforming growth factor-beta-related gene family. CM Jones D Simon-Chazottes JL Guenet BL Hogan, Mol Endocrinol 1992 61 1961 1968 10.1210/me.6.11.1961
2. GDF-3 and GDF-9: two new members of the transforming growth factor-beta superfamily containing a novel pattern of cysteines. AC McPherron SJ Lee, J Biol Chem 1993 268 3444 3449 8429021
3. Human growth-differentiation factor 3 (hGDF3): developmental regulation in human teratocarcinoma cell lines and expression in primary testicular germ cell tumours. AA Caricasole RH van Schaik LM Zeinstra CD Wierikx RJ van Gurp M van den Pol LH Looijenga JW Oosterhuis MF Pera A Ward D de Bruijn P Kramer FH de Jong AJ van den Eijnden-van Raaij, Oncogene 1998 16 95 103 10.1038/sj.onc. 1201515 9467948
4. Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. UI Ezeh PJ Turek RA Reijo AT Clark, Cancer 2005 104 2255 2265 10.1002/cncr.21432 16228988
5. Novel genomic aberrations in testicular germ cell tumors by array-CGH, and associated gene expression changes. RI Skotheim R Autio GE Lind SM Kraggerud PW Andrews O Monni O Kallioniemi RA Lothe, Cell Oncol 2006 28 315 326 17167184
6. Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, SOX2 and GDF3, with emphasis on morphologically difficult-to-classify areas. A Gopalan D Dhall S Olgac SW Fine JE Korkola J Houldsworth RS Chaganti GJ Bosl VE Reuter SK Tickoo, Mod Pathol 2009 22 1066 1074 10.1038/modpathol.2009.66 19396148
7. Human STELLAR, NANOG, and GDF3 genes are expressed in pluripotent cells and map to chromosome 12p13, a hotspot for teratocarcinoma. AT Clark RT Rodriguez MS Bodnar MJ Abeyta MI Cedars PJ Turek MT Firpo RA Reijo Pera, Stem Cells 2004 22 169 179 10.1634/stemcells.22-2-169 14990856
8. GDF3 at the crossroads of TGF-beta signaling. AJ Levine AH Brivanlou, Cell Cycle 2006 5 1069 1073 16721050
9. GDF3, a BMP inhibitor, regulates cell fate in stem cells and early embryos. AJ Levine AH Brivanlou, Development 2006 133 209 216 10.1242/dev.02192 16339188
10. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. K Takahashi S Yamanaka, Cell 2006 126 663 676 10.1016/j.cell.2006.07.024 16904174
11. The Vg1-related protein Gdf3 acts in a Nodal signaling pathway in the pre-gastrulation mouse embryo. C Chen SM Ware A Sato DE Houston-Hawkins R Habas MM Matzuk MM Shen CW Brown, Development 2006 133 319 329 10.1242/dev.02210 16368929
12. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. T Lapidot C Sirard J Vormoor B Murdoch T Hoang J Caceres-Cortes M Minden B Paterson MA Caligiuri JE Dick, Nature 1994 367 645 648 10.1038/367645a0 7509044
13. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. JE Visvader GJ Lindeman, Nat Rev Cancer 2008 8 755 768 10.1038/nrc2499 18784658
14. Identification of cells initiating human melanomas. T Schatton GF Murphy NY Frank K Yamaura AM Waaga-Gasser M Gasser Q Zhan S Jordan LM Duncan C Weishaupt RC Fuhlbrigge TS Kupper MH Sayegh MH Frank, Nature 2008 451 345 349 10.1038/nature06489 18202660
15. Efficient tumour formation by single human melanoma cells. E Quintana M Shackleton MS Sabel DR Fullen TM Johnson SJ Morrison, Nature 2008 456 593 598 10.1038/nature07567 19052619
16. Isolation and identification of cancer stem-like cells from murine melanoma cell lines. J Dou M Pan P Wen Y Li Q Tang L Chu F Zhao C Jiang W Hu K Hu N Gu, Cell Mol Immunol 2007 4 467 472 18163959
17. Cancer stem cells sustaining the growth of mouse melanoma are not rare. Y Zhong K Guan C Zhou W Ma D Wang Y Zhang S Zhang, Cancer Lett 2010 292 17 23 10.1016/j.canlet.2009.10.021 19944522
18. Differential expression of the novel oncogene, SALL4, in lymphoma, plasma cell myeloma, and acute lymphoblastic leukemia. W Cui NR Kong Y Ma HM Amin R Lai L Chai, Mod Pathol 2006 19 1585 1592 10.1038/modpathol.3800694 16998462
19. SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice. Y Ma W Cui J Yang J Qu C Di HM Amin R Lai J Ritz DS Krause L Chai, Blood 2006 108 2726 2735 10.1182/blood-2006-02-001594 16763212
20. Identification of Kruppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. W Zhao IM Hisamuddin MO Nandan BA Babbin NE Lamb VW Yang, Oncogene 2004 23 395 402 10.1038/sj.onc.1207067 14724568
21. Drastic down-regulation of Kruppel-like factor 4 expression is critical in human gastric cancer development and progression. D Wei W Gong M Kanai C Schlunk L Wang JC Yao TT Wu S Huang K Xie, Cancer Res 2005 65 2746 2754 10.1158/0008-5472.CAN-04-3619 15805274
22. Downregulation and growth inhibitory effect of epithelial-type Kruppel-like transcription factor KLF4, but not KLF5, in bladder cancer. S Ohnishi S Ohnami F Laub K Aoki K Suzuki Y Kanai K Haga M Asaka F Ramirez T Yoshida, Biochem Biophys Res Commun 2003 308 251 256 10.1016/S0006-291X(03) 01356-1 12901861
23. Overexpression of Kruppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenecity. DT Dang X Chen J Feng M Torbenson LH Dang VW Yang, Oncogene 2003 22 3424 3430 10.1038/sj.onc.1206413 12776194
24. Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. AY Pandya LI Talley AR Frost TJ Fitzgerald V Trivedi M Chakravarthy DC Chhieng WE Grizzle JA Engler H Krontiras KI Bland AF LoBuglio SM Lobo-Ruppert JM Ruppert, Clin Cancer Res 2004 10 2709 2719 10.1158/1078-0432.CCR-03-0484 15102675
25. Nuclear Kruppel-like factor 4 expression is associated with human skin squamous cell carcinoma progression and metastasis. YJ Chen CY Wu CC Chang CJ Ma MC Li CM Chen, Cancer Biol Ther 2008 7 777 782 18376139
26. Induction of KLF4 in basal keratinocytes blocks the proliferation- differentiation switch and initiates squamous epithelial dysplasia. KW Foster Z Liu CD Nail X Li TJ Fitzgerald SK Bailey AR Frost ID Louro TM Townes AJ Paterson JE Kudlow SM Lobo-Ruppert JM Ruppert, Oncogene 2005 24 1491 1500 10.1038/sj.onc.1208307 15674344
27. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. QL Ying J Nichols I Chambers A Smith, Cell 2003 115 281 292 10.1016/S0092-8674(03)00847-X 14636556
28. Bottaro DP. Grb2 signaling in cell motility and cancer. A Giubellino TR Burke Jr, Expert Opin Ther Targets 2008 12 1021 1033 10.1517/14728222.12.8.1021 18620523
29. Involvement of phosphoinositide 3-kinase in regulation of adhesive activity of highly metastatic hepatoma cells. Y Saeki T Seya K Hazeki M Ui O Hazeki H Akedo, J Biochem 1998 124 1020 1025 9792928
30. A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Y Kang CR Chen J Massague, Mol Cell 2003 11 915 926 10.1016/S1097-2765(03)00109-6 12718878
31. Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors. M Schindl SF Schoppmann T Strobel H Heinzl C Leisser R Horvat P Birner, Clin Cancer Res 2003 9 779 785 12576450
32. An attempt to isolate genes responsible for spontaneous and experimental metastasis in the mouse model. A Ito K Watabe Y Koma Y Kitamura, Histol Histopathol 2002 17 951 959 12168807
33. Roles of Sall4 in the generation of pluripotent stem cells from blastocysts and fibroblasts. N Tsubooka T Ichisaka K Okita K Takahashi M Nakagawa S Yamanaka, Genes Cells 2009 14 683 694 10.1111/j.1365-2443.2009.01301. x 19476507
34. Caretaker tumour suppressor genes that defend genome integrity. NC Levitt ID Hickson, Trends Mol Med 2002 8 179 186 10.1016/S1471-4914(02)02298-0 11927276
35. CD24 expression is a new prognostic marker in breast cancer. G Kristiansen KJ Winzer E Mayordomo J Bellach K Schluns C Denkert E Dahl C Pilarsky P Altevogt H Guski M Dietel, Clin Cancer Res 2003 9 4906 4913 14581365
36. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery. XR Yang Y Xu B Yu J Zhou JC Li SJ Qiu YH Shi XY Wang Z Dai GM Shi B Wu LM Wu GH Yang BH Zhang WX Qin J Fan, Clin Cancer Res 2009 15 5518 5527 10.1158/1078-0432.CCR-09-0151 19706825
37. CD24-Siglec G/10 discriminates danger- from pathogen-associated molecular patterns. Y Liu GY Chen P Zheng, Trends Immunol 2009 30 557 561 10.1016/j.it.2009.09.006 19786366
38. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. GY Chen J Tang P Zheng Y Liu, Science 2009 323 1722 1725 10.1126/science.1168988 19264983